Adalimumab-aaty (1 Pen) coupons
Adalimumab-aaty (1 Pen)

Adalimumab-aaty (1 Pen) Coupons & Savings Card – Discount Prices from $530.72

Adalimumab is a medication used to alleviate pain and swelling associated with certain types of arthritis, including rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis. It is also effective in treating specific skin conditions like plaque psoriasis and hidradenitis suppurativa. The drug works by blocking a protein called tumor necrosis factor (TNF), which is part of the immune system and is responsible for causing inflammation and damage in the joints and skin. As a TNF blocker, Adalimumab helps to reduce joint swelling, prevent further joint damage, and maintain joint functionality. Additionally, it is used to manage certain bowel conditions, such as Crohn's disease and ulcerative colitis, and an eye condition known as uveitis. This information pertains to various forms of Adalimumab, including adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk.
Our coupons are free to use. Before paying, show the pharmacist your Adalimumab-aaty (1 Pen) savings card to get your free discount. Use our filters below to edit the prescription box to match your needs. The Adalimumab-aaty (1 Pen) prices will update based on your prescription needs. Above our Adalimumab-aaty (1 Pen) coupons, you can change your location to see pharmacy prices and costs in other areas. We're here to help you buy Adalimumab-aaty (1 Pen) at the lowest price with our prescription discount card.

My prescription

Edit

40MG/0.4ML, Adalimumab-aaty (1 Pen) (1 Auto-injector Kit)

Select pharmacy

Pharmacy logo

Walgreens

$530.72

COUPON PRICE
Pharmacy logo

Albertsons

$532.65

COUPON PRICE
Pharmacy logo

Walmart

$561.70

COUPON PRICE

Adalimumab-aaty (1 Pen) savings card

Show this card to your pharmacist
Pharmacy logo

Walgreens

$530.72

BIN

ID

PCN

GRP

019876

LHE1FBC718

CHIPPO

LHX

Powered by

This card is not insurance

Price history for Adalimumab-aaty (1 Pen) (generic)

1, 40MG/0.4ML

Average retail price for Adalimumab-aaty (1 Pen)

Average SaveHealth price for Adalimumab-aaty (1 Pen)

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

We analyzed Adalimumab-aaty (1 Pen) prices for (40MG/0.4ML, 1 Auto-injector Kit) over the last 12 months. The average retail price was $1780.08, while the average price using the SaveHealth discount card was $536.92. That's a savings of approximately 69.84% when using our Adalimumab-aaty (1 Pen) coupon.

Adalimumab-aaty (1 Pen) dosage forms

Use our Adalimumab-aaty (1 Pen) 40MG/0.4ML coupon with prices from $530.72 for 1 Auto-injector Kit. You can also use our Adalimumab-aaty (1 Pen) 80MG/0.8ML coupon with prices from $530.72 for 1 Auto-injector Kit.
DosageQuantityPrice fromPer unit
40MG/0.4ML1 Auto-injector Kit$530.72$530.72
80MG/0.8ML1 Auto-injector Kit$530.72$530.72

Adalimumab-aaty (1 Pen) Warnings

This medication can decrease your body's ability to fight an infection. This effect can lead to very serious (possibly fatal) infections (such as fungal infections, bacterial infections including tuberculosis). Tell your doctor your medical history, especially of past/recent/current infections. You should also tell your doctor if you have lived or traveled in areas where certain fungal infections (such as coccidioidomycosis, histoplasmosis) are common or if you have been near someone with tuberculosis. Areas where these types of fungal infections are commonly found include the Ohio and Mississippi River valleys and the southwestern United States. Tell your doctor right away if you develop signs of infection (see Side Effects section). Your doctor will test you for tuberculosis (TB) infection before and during treatment with this drug. If you are diagnosed with TB, your doctor will first prescribe treatment for this to prevent a serious TB infection while using adalimumab. Though it is very unlikely to happen, there is a risk (especially in children/teens/young adults) of developing cancer (such as lymphoma, skin cancer) due to this medication or due to your medical condition. Discuss the risks and benefits of treatment with your doctor. Tell your doctor right away if you develop symptoms such as a fever that doesn't go away, unusual lumps/growths, swollen lymph nodes, unexplained weight loss, or night sweats.

Adalimumab-aaty (1 Pen) Side Effects

No information available.

Adalimumab-aaty (1 Pen) Interactions

Some products that may interact with this drug include: other TNF blockers (such as etanercept, infliximab), other drugs that weaken the immune system (such as abatacept, anakinra).
Adalimumab-aaty (1 Pen) FAQs
What is the difference between adalimumab and Humira?

Adalimumab is the generic name for the medication, while Humira is the brand name. Both refer to the same drug, which is used to treat various autoimmune conditions.

The duration for which a patient can stay on adalimumab varies depending on the individual's condition and response to the medication. Many patients use adalimumab as a long-term treatment under the guidance of their healthcare provider. It is important for patients to have regular follow-ups with their healthcare provider to monitor the effectiveness and any potential side effects of the medication. The decision to continue or discontinue adalimumab should always be made in consultation with a healthcare professional.

Yes, adalimumab is the generic name for the brand name drug Humira. They are the same medication.

Individuals who should not take adalimumab include those with a known hypersensitivity to adalimumab or any of its components. Additionally, it is generally not recommended for individuals with active infections, such as tuberculosis or other severe infections, due to the risk of exacerbating these conditions. Patients with a history of recurrent infections or underlying conditions that predispose them to infections should use adalimumab with caution. It is important for individuals to consult with their healthcare provider to determine if adalimumab is appropriate for their specific medical condition.

Long-term use of adalimumab can lead to several potential effects. Patients may experience an increased risk of infections due to the suppression of the immune system. There is also a potential for the development of certain types of cancers, such as lymphoma and skin cancer. Other possible long-term effects include liver damage, heart failure, and the development of autoimmune conditions like lupus-like syndrome. Regular monitoring by a healthcare provider is essential to manage these risks effectively.